Business Wire

NY-THE-GOOD-SOCIETY

9.8.2022 19:02:10 CEST | Business Wire | Press release

Share
Nonprofit Funding Platform Heroe5 Launches The Good Society, Embracing Web3 Approach to the Sustainable Financial Benefit for Charities

Nonprofit funding platform Heroe5™ announced today the creation of The Good Society to address the growing need for sustainable funding platforms for charitable organizations. The Good Society becomes the first project focused on Web3 solutions to raise awareness and support global causes working to positively impact our communities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220728005376/en/

“The Good Society is a vital next step in the evolution of the fundraising industry: a Web3 platform to create art impact experiences,” said Sebastien Heimann, founding member and CEO of Heroe5 and The Good Society. “As the world moves to Web3, charities need more fundraising tools to stay ahead of the curve and embrace new ways to engage potential donors. The Good Society will provide those innovations, allowing them to raise critical funding and awareness for vital causes while feeding the public’s growing interest in digital collectables.”

With each drop 1800 digital collectibles designed by acclaimed artists will be released each month supporting a broad range of nonprofits working to improve the environment, wildlife, human rights, and our collective health and wellbeing. A percentage of these art impact experiences will grant token carriers access to unique events in perpetuity.

Artist Nate Mohler created “Out of Sight | Out of Mind” for The Good Society’s first program, which benefits Lonely Whale , No More Plastic , and Oceanic Global . The digital collectables, scaled to 3840 x 3840 pixels, 26 seconds in length and layered with “white sound,” emphasize the risk to fragile ocean ecosystems from the human-caused plastic pollution in urban environments and highlight how much there is left to learn. Three of the many cities featured in “Out of Sight | Out of Mind” include London , Los Angeles , and Paris .

“No matter where you live, the oceans provide the oxygen you breathe, nurture the food you eat, and regulate the temperature of the air. Without a healthy ocean we’d have a very different experience on land,” said Mohler. “This series is not of the oceans but of major cities, which emit 60% of all carbon emissions and make up less than 1% of the Earth’s surface. Similar to my ongoing series ‘Painted Cities’ there are three unique styles intended to bring a more ephemeral and dreamlike memory of the city.”

One of every 15 of the digital collectibles will also provide owners access to experiences that are provided by the benefiting organizations and artists for each drop. Some of the experiences tied to this premier release include:

  • Two front row seats at Paris Fashion Week
  • Two passes to Oceanic Global’s annual gathering for ocean conservation
  • An annual artist critique call with Nate Mohler
  • Invitations to Lonely Whale's annual leadership virtual town hall which discuss its programs and preview its impact report

Digital collectors will easily be able to purchase the artwork with a credit card or Tez, cryptocurrency of the Tezos blockchain, when they are minted on August 12 at 2pm ET. Once sold out, more than $1M (US) in new funding will be available to the benefiting organizations and, as the digital collectables are resold, the organizations will receive residual payments from each transaction.

Quotes from Benefiting Organizations

“Lonely Whale’s goal is simple - to keep plastic out of the ocean. We want to thank each person who buys one of Nate Mohler’s striking NFTs through The Good Society, which will support the creative development and market adoption of alternatives to thin-film plastic and directly address the nearly 180 billion polybags used every year by the fashion industry.” Harry Bernstein, Chief Creative Officer, Lonely Whale

“Plastic pollution has become one of the biggest environmental scourges of our time. Microplastics are everywhere: in the deep ocean, in Antarctic ice, even falling rain over mountains and cities. Plastic pollution not only pollutes our planet; it pollutes our blood. We must act and the time is now. We are grateful to The Good Society for entrusting No More Plastic Foundation with this generous funding. With it, we will continue our work to end the cycle of plastics and microplastics flowing into our ocean.” Rosalie Mann, Founder & President, No More Plastic

“We live on a blue planet. The ocean covers 70% of the surface of the earth and produces every other breath we take. Our well-being is intrinsically tied to the ocean. Thanks to The Good Society and their innovative fundraising platform and model – and to artiste extraordinaire Nate Mohler – Oceanic Global will be able to keep empowering individuals, communities, and industries to create positive change for a thriving ocean.” – Lea d'Auriol, Founder & Executive Director, Oceanic Global

About The Good Society
The Good Society harnesses the power of non fungible tokens to fund global initiatives. Designed by acclaimed digital artists, every month a new NFT will drop that raises awareness and secures funding for nonprofits working to improve the environment, human rights, and our collective health and wellbeing. Led by Sebastien Heimann, the Co-founder & CEO of fundraising platform Heroe5, The Good Society leverages the uniqueness of Web3 to deliver a powerful and recurring source of funding. For more information visit thegoodsociety.org .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release

FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release

In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye